Feasibility, Multi-center Prospective Study of Check-Cap's P1 Capsule System in Patients Eligible for ColoRectal Cancer [CRC] Screening
Check-Cap Ltd.'s P1 Capsule System aims to provide a non-invasive alternative for colorectal cancer screening, particularly for patients with negative FOBT results. The market for colorectal cancer screening is substantial, driven by increasing awareness and guidelines recommending regular screenings for individuals aged 45 and older. The competitive landscape includes traditional methods like colonoscopy and CT colonography, as well as emerging technologies in capsule endoscopy. The successful demonstration of safety and preliminary efficacy could position Check-Cap favorably in the market, although the termination of this trial indicates that further studies may be necessary to validate its clinical utility and secure regulatory approval.
Indication: ColoRectal Cancer
Modality: medical device
Target: Colorectal cancer screening via imaging of the colon internal surface using the Check-Cap P1 Capsule System.
Sponsor: Check-Cap Ltd.
Source URL: ClinicalTrials.gov
Source updated: Feb 04, 2019
Ingested: Jun 16, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Colorectal cancer screening via imaging of the colon internal surface using the Check-Cap P1 Capsule System.
View original source fields
Condition raw: ColoRectal Cancer, Colonic Polyps
Condition normalized: ColoRectal Cancer, Colonic Polyps
Modality raw: medical device
Modality normalized: medical device
Target raw: Colorectal cancer screening via imaging of the colon internal surface using the Check-Cap P1 Capsule System.
Target normalized: Colorectal cancer screening via imaging of the colon internal surface using the Check-Cap P1 Capsule System.